Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Griseofulvin ultramicrosize |
Is a |
False |
Griseofulvin (substance) |
Inferred relationship |
Some |
|
Griseofulvin microsize |
Is a |
False |
Griseofulvin (substance) |
Inferred relationship |
Some |
|
Griseofulvin measurement |
Component |
True |
Griseofulvin (substance) |
Inferred relationship |
Some |
1 |
Accidental griseofulvin poisoning |
Causative agent (attribute) |
False |
Griseofulvin (substance) |
Inferred relationship |
Some |
|
Intentional griseofulvin poisoning |
Causative agent (attribute) |
False |
Griseofulvin (substance) |
Inferred relationship |
Some |
|
intoxication par la griséofulvine d'intention indéterminée |
Causative agent (attribute) |
False |
Griseofulvin (substance) |
Inferred relationship |
Some |
1 |
Griseofulvin adverse reaction |
Causative agent (attribute) |
True |
Griseofulvin (substance) |
Inferred relationship |
Some |
1 |
Allergy to griseofulvin (finding) |
Causative agent (attribute) |
False |
Griseofulvin (substance) |
Inferred relationship |
Some |
|
Griseofulvin overdose |
Causative agent (attribute) |
True |
Griseofulvin (substance) |
Inferred relationship |
Some |
1 |
Accidental griseofulvin overdose |
Causative agent (attribute) |
True |
Griseofulvin (substance) |
Inferred relationship |
Some |
1 |
Intentional griseofulvin overdose |
Causative agent (attribute) |
True |
Griseofulvin (substance) |
Inferred relationship |
Some |
1 |
surdose de griséofulvine d'intention indéterminée |
Causative agent (attribute) |
False |
Griseofulvin (substance) |
Inferred relationship |
Some |
1 |
Griseofulvin 125 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Griseofulvin (substance) |
Inferred relationship |
Some |
|
Griseofulvin 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Griseofulvin (substance) |
Inferred relationship |
Some |
|
Griseofulvin 250 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Griseofulvin (substance) |
Inferred relationship |
Some |
|
Griseofulvin 165 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Griseofulvin (substance) |
Inferred relationship |
Some |
|
Griseofulvin 330 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Griseofulvin (substance) |
Inferred relationship |
Some |
|
Griseofulvin 250 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Griseofulvin (substance) |
Inferred relationship |
Some |
|
Product containing precisely griseofulvin 25 milligram/1 milliliter conventional release oral suspension (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Griseofulvin (substance) |
Inferred relationship |
Some |
|
Griseofulvin ultramicrosize 125 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Griseofulvin (substance) |
Inferred relationship |
Some |
|
Griseofulvin ultramicrosize 165 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Griseofulvin (substance) |
Inferred relationship |
Some |
|
Griseofulvin ultramicrosize 330 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Griseofulvin (substance) |
Inferred relationship |
Some |
|
Griseofulvin, microsize 125mg/5mL suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Griseofulvin (substance) |
Inferred relationship |
Some |
|
Griseofulvin microsize 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Griseofulvin (substance) |
Inferred relationship |
Some |
|
Griseofulvin microsize 250 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Griseofulvin (substance) |
Inferred relationship |
Some |
|
Griseofulvin, microsize 125mg/mL suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Griseofulvin (substance) |
Inferred relationship |
Some |
|
Griseofulvin ultramicrocrystalline 330mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Griseofulvin (substance) |
Inferred relationship |
Some |
|
Griseofulvin ultramicrosize 250 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Griseofulvin (substance) |
Inferred relationship |
Some |
|
Griseofulvin ultramicrocrystalline 165mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Griseofulvin (substance) |
Inferred relationship |
Some |
|
Griseofulvin microsize 250 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Griseofulvin (substance) |
Inferred relationship |
Some |
|
Poisoning by griseofulvin |
Causative agent (attribute) |
True |
Griseofulvin (substance) |
Inferred relationship |
Some |
1 |
Product containing griseofulvin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Griseofulvin (substance) |
Inferred relationship |
Some |
1 |
Product containing griseofulvin microsize |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Griseofulvin (substance) |
Inferred relationship |
Some |
|
Accidental griseofulvin poisoning |
Causative agent (attribute) |
True |
Griseofulvin (substance) |
Inferred relationship |
Some |
1 |
Intentional griseofulvin poisoning |
Causative agent (attribute) |
True |
Griseofulvin (substance) |
Inferred relationship |
Some |
1 |
Griseofulvin 10 mg/mL cutaneous spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Griseofulvin (substance) |
Inferred relationship |
Some |
|
Griseofulvin-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Griseofulvin (substance) |
Inferred relationship |
Some |
1 |
Product containing griseofulvin in topical dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Griseofulvin (substance) |
Inferred relationship |
Some |
|
Allergy to griseofulvin (finding) |
Causative agent (attribute) |
True |
Griseofulvin (substance) |
Inferred relationship |
Some |
1 |
Griseofulvin 125 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Griseofulvin (substance) |
Inferred relationship |
Some |
1 |
Griseofulvin 125 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Griseofulvin (substance) |
Inferred relationship |
Some |
1 |
Griseofulvin 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Griseofulvin (substance) |
Inferred relationship |
Some |
1 |
Griseofulvin 500 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Griseofulvin (substance) |
Inferred relationship |
Some |
1 |
Griseofulvin 250 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Griseofulvin (substance) |
Inferred relationship |
Some |
1 |
Griseofulvin 250 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Griseofulvin (substance) |
Inferred relationship |
Some |
1 |
Griseofulvin 165 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Griseofulvin (substance) |
Inferred relationship |
Some |
1 |
Griseofulvin 165 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Griseofulvin (substance) |
Inferred relationship |
Some |
1 |
Griseofulvin 330 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Griseofulvin (substance) |
Inferred relationship |
Some |
1 |
Griseofulvin 330 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Griseofulvin (substance) |
Inferred relationship |
Some |
1 |
Griseofulvin 250 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Griseofulvin (substance) |
Inferred relationship |
Some |
1 |
Griseofulvin 250 mg oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Griseofulvin (substance) |
Inferred relationship |
Some |
1 |
Griseofulvin microsize |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Griseofulvin (substance) |
Inferred relationship |
Some |
|
Griseofulvin ultramicrosize |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Griseofulvin (substance) |
Inferred relationship |
Some |
|
Griseofulvin 250 mg oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Griseofulvin (substance) |
Inferred relationship |
Some |
1 |
Griseofulvin 125 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Griseofulvin (substance) |
Inferred relationship |
Some |
1 |
Griseofulvin 250 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Griseofulvin (substance) |
Inferred relationship |
Some |
1 |
Griseofulvin 500 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Griseofulvin (substance) |
Inferred relationship |
Some |
1 |
Griseofulvin 165 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Griseofulvin (substance) |
Inferred relationship |
Some |
1 |
Griseofulvin 330 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Griseofulvin (substance) |
Inferred relationship |
Some |
1 |
Product containing griseofulvin in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Griseofulvin (substance) |
Inferred relationship |
Some |
1 |
Product containing only griseofulvin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Griseofulvin (substance) |
Inferred relationship |
Some |
1 |
Product containing only griseofulvin in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Griseofulvin (substance) |
Inferred relationship |
Some |
1 |
Griseofulvin only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Griseofulvin (substance) |
Inferred relationship |
Some |
1 |
Griseofulvin 10 mg/mL cutaneous spray |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Griseofulvin (substance) |
Inferred relationship |
Some |
1 |
Griseofulvin 10 mg/mL cutaneous spray |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Griseofulvin (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely griseofulvin 25 milligram/1 milliliter conventional release oral suspension (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Griseofulvin (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely griseofulvin 25 milligram/1 milliliter conventional release oral suspension (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Griseofulvin (substance) |
Inferred relationship |
Some |
1 |